HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women.

Abstract
Topical dapsone 5% gel for the treatment of mild to moderate acne has been shown to be effective in randomized controlled studies. A total of 101 adult women with mild to moderate facial inflammatory acne participated in a 12-week cohort study to evaluate the efficacy, tolerability, and safety of dapsone gel 5% in this specific group who often complain of sensitive skin. The women were instructed to apply dapsone 5% gel twice daily after washing their face with a standard noncomedogenic soap-free cleanser. Treatment outcome was evaluated using physician-scored Global Acne Assessment Scale (GAAS) and patient-reported facial skin condition. Ninety-three women completed the study (6 were lost to follow-up and 2 had mild skin irritation). At 12 weeks, significant physician GAAS scores (t55 = 8.85, P = .001) and patient-reported lesion reductions were shown. Treatment success (GAAS 0 or 1) at 12 weeks was achieved in 69.4% (n = 75) of women (t94 = 4.17, P = .001), improving patient-reported quality-of-life aspects. Topical dapsone gel 5% was shown to be safe, minimally irritating, and effective in the treatment of mild to moderate inflammatory facial acne in adult women with sensitive skin.
AuthorsCharles W Lynde, Anneke Andriessen
JournalSkinmed (Skinmed) 2014 Jan-Feb Vol. 12 Issue 1 Pg. 15-21 ISSN: 1540-9740 [Print] United States
PMID24720080 (Publication Type: Journal Article)
Chemical References
  • Dermatologic Agents
  • Gels
  • Dapsone
Topics
  • Acne Vulgaris (drug therapy, pathology)
  • Administration, Cutaneous
  • Adolescent
  • Adult
  • Aged
  • Cohort Studies
  • Dapsone (administration & dosage, adverse effects, therapeutic use)
  • Dermatologic Agents (administration & dosage, adverse effects, therapeutic use)
  • Face
  • Female
  • Follow-Up Studies
  • Gels
  • Humans
  • Inflammation (drug therapy, pathology)
  • Middle Aged
  • Quality of Life
  • Severity of Illness Index
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: